Malignant Solid Neoplasm — Trials

Malignant Solid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

900 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 429
Recruiting: 209
Ph III recruiting: 10
Growth YoY: +2.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (101)

clinicaltrialsPublishedShowing 51–56 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07002502	Immune Modulation With PRaG-1 Treatment	not yet recruiting	Phase 2	19	Second Affiliated Hospital of Soochow UniversityOTHER	0	Jun 10, 2025	clinicaltrials
NCT06999538	Real-life Performance Evaluation of the LiFlow X-ray Platform(LiFE)	not yet recruiting	—	400	University Hospital, AngersOTHER_GOV	0	May 31, 2025